Go back

Patients to have more influence on commercial clinical trials

Patients are set to have a greater say in the design of commercial clinical trials as the National Institute for Health Research rolls out a patient engagement service.

A pilot version of the service has undergone testing with the pharmaceutical company Pfizer in 2018 and earlier this year. The service is now being tested by several life science companies. Its aim is to enable patients to be involved earlier in the clinical development process so that clinical trial designs are “as patient-friendly as they can be”, the NIHR said on 3 May.

William van’t Hoff, the clinical director for NHS engagement for the NIHR Clinical Research Network, a member of the project team, said that patients can give valuable insights into clinical-trial design.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.